New treatments for inflammatory bowel disease

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

314

HTML

2111

Tables (1-2)

157

Sum=2582

Oct 15, 1998 (publication date) through Jul 17, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorials

World J Gastroenterol. Oct 15, 1998; 4(5): 369-376
Published online Oct 15, 1998. doi: 10.3748/wjg.v4.i5.369

Table 1 New formulations and applications of existing therapies for IBD

Treatment	References
Corticosteroids
Budesonide	14-18
Aminosalicylates
Mesalazine (enteric-coated pH-released & slow-release),
olsalazine, balsalazide	4,5,19-22
Immunomodulatory agents
Azathioprine & 6-mercaptopurine	23-29
Cyclosporine	30,31
Methotrexate	32,33
Mycophenolate mofetil	34
Antibiotics
Metronidazole	35-37
Other	38
Liquid formula diet	39,40

Citation: Rampton DS, Phil D. New treatments for inflammatory bowel disease. World J Gastroenterol 1998; 4(5): 369-376
URL: https://www.wjgnet.com/1007-9327/full/v4/i5/369.htm
DOI: https://dx.doi.org/10.3748/wjg.v4.i5.369